US$ 22.94
contraindications of glp 1 agonist Exploring the Side Effects GLP-1 Receptor Agonist: To Ensure Its Optimal Positioning Non-insulin injectable antidiabetic drugs -
Description
With Transcend, Lilly had a full picture of data, to the point that they published the data in The Lancet, but the trial was only 40 weeks long and multiple endpoints including A1c, weight loss and other markers havent quite hit the full potential of the drug for diabetics so were left with questions on what happens when you take it for a longer term

Mitochondria and anti-oxidants The neuroprotection of GLP-1RAs is attributed to the restoration of mitochondrial function, reduction of oxidative stress, and prevention of subsequent apoptosis

Yes, regular exercise enhances its benefits

Chakhtoura M et al

2023;12(18):e028409
